Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 851 to 875 of about 5880

Previous 25

Website Changes

06/29/2020

We need your supprt for the Promising Pathway Act

06/29/2020

A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study

06/28/2020

David Zagzag, MD, Ph.D. Recognized as a Professional of the Year for 2020 by Strathmore`s Who`s Who Worldwide

06/27/2020

ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP

06/25/2020

A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas

06/24/2020

Musella Foundation Copay Program now closed to new patients

06/24/2020

New class of precision medicine strips cancer of its DNA defenses

06/24/2020

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II

06/22/2020

Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease

06/21/2020

Brain Tumor Webinars continue tonight! Sunday 6/21/2020 7pm Eastern Time

06/18/2020

Gallagher, Colleagues Introduce Bipartisan Promising Pathways Act

06/15/2020

Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma

06/15/2020

Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice

06/15/2020

The Musella Foundation Awards 2 Brain Tumor Research Grants

06/15/2020

Cancer Vaccine Plus Adoptive T-cell Therapy Placed on Fast Track

06/13/2020

Brain Tumor Webinar Series continues tonight! 6/14/2020

06/13/2020

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals` VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme

06/07/2020

Brain Tumor Webinars continue tonight!

06/05/2020

The McDowell Family Lost A Child To Cancer And Now They Are Creating a Tourist Attraction to Fund Research– So Why Are Some Of The Neighbors So Angry?

06/02/2020

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

06/02/2020

First Patient Treated in Phase 1 Clinical Trial Of Incysus Therapeutics Gamma Delta (?d) T Cell Immunotherapy for Patients With Newly Diagnosed Glioblastoma

06/02/2020

Factors Affecting Survival in Glioblastoma: A 10-year Single-Center Experience From Saudi Arabia

06/01/2020

Phase 2a study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K / mTOR inhibitor GDC-0084 given to glioblastoma (GBM) patients with unmethylated MGMT promotor status

05/29/2020

ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.

05/29/2020

Al Musella`s ASCO Hightlights

Our privacy / cookie policy has changed.
Click HERE to read it!